NDC 50090-2183-00 - Cryselle
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-2183
- Requested NDC
- 50090-2183-00
- Package NDCs from labels
- 50090-2183-0, 50090-2183-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-05-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cryselle - A-S Medication Solutions | A-S Medication Solutions | 2024-05-07 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2023-02-07 | Cryselle ® (norgestrel and ethinyl estradiol tablets USP) |
| 2023-01-30 | Cryselle ® (norgestrel and ethinyl estradiol tablets USP) |
| 2020-02-14 | Cryselle ® (norgestrel and ethinyl estradiol tablets USP) |
| 2020-01-31 | Cryselle ® (norgestrel and ethinyl estradiol tablets USP) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-2183-0 | Cryselle | 1 in 1 KIT | KIT | 1 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-2183 | CRYSELLE (NORGESTREL AND ETHINYL ESTRADIOL) KIT [A-S MEDICATION SOLUTIONS] | 15 | Current NDC, Legacy NDC, 1 package rows | 20240511_fcf4f8ea-1eb3-4a43-87d2-16f93e904443.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-2183-0 | EA - Each | 50090-2183 | f1d8550c-093a-4ab8-af66-8d8e094ded4f | 1 | 2019-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VIORELE | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 39988aa6-8f68-40e8-9bdd-c40a3bdaad61 | 2026-01-31 | Boxed warning, Warnings, Adverse reactions | 748797 |
| ALYACEN 1/35 | NORETHINDRONE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 5c02b4d3-1e2f-439a-ae45-02304ee190d1 | 2026-01-31 | Warnings, Adverse reactions | 748797 |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 44fbc5ae-5682-471f-a12a-955e8b4d233a | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| levonorgestrel and ethinyl estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 3d87d9a4-860a-4ea7-a993-0f4adf1789da | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Norethindrone Acetate and Ethinyl Estradiol | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 5a44f7a2-45f1-4d28-b9fb-61d9f2456422 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Hailey 1.5/30 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 021df70a-0c37-4237-a2f7-2597ff6d41f5 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| drospirenone and ethinyl estradiol | DROSPIRENONE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 0f8f8a21-cee8-462f-98b3-6c06f2f33e0d | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Norethindrone Acetate and Ethinyl Estradiol | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | cf549b5a-2707-4020-9f94-dab1260e1664 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| MARLISSA | LEVONORGESTREL AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 9379d99e-c416-4dab-a817-1c110e0d4b93 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Tri-Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | f7f7c073-48e0-4065-970b-8103d76b6eb0 | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | 748797 |
| ZAFEMY | NORELGESTROMIN AND ETHINYL ESTRADIOL | AvKARE | fbbd12dd-c538-2869-e053-6294a90a1a38 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Lubricant Eye Drops Solution | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | AvPAK | f5743b38-e3d2-a065-e053-2995a90a4b9a | 2026-01-08 | Warnings | B697894SGQ |
| Fyavolv | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 772c86d7-10a4-48c5-8c19-f8aac68f5ab4 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| ALYACEN 1/35 | NORETHINDRONE AND ETHINYL ESTRADIOL | Proficient Rx LP | fa32e05b-c86d-4743-aee5-be3fc515152b | 2026-01-01 | Warnings, Adverse reactions | 748797 |
| Value Health by Prodose Eye Drops | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 | Prodose, Inc. | 3fafa362-a8a6-3f91-e063-6394a90a98b3 | 2025-12-31 | Warnings | B697894SGQ |
| Signature Care Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Better Living Brands LLC | 6f1f4f58-3208-4b06-9afb-c4beeed09314 | 2025-12-30 | Warnings | B697894SGQ |
| Target Lubricant Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Target Corporation | 6c449374-8847-4c4a-9073-1951ff31d404 | 2025-12-30 | Warnings | B697894SGQ |
| Target Lubricant Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Target Corporation | ddc15dac-fbd8-42fa-80db-79f49fc6b9eb | 2025-12-30 | Warnings | B697894SGQ |
| CVS Advanced Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | CVS Pharmacy, Inc. | f74a2fca-902c-f68a-e053-6394a90abb88 | 2025-12-30 | Warnings | B697894SGQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.